Hereditary Genetic Testing Market By Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutri-genomic Testing), By Application (Cancer, Genetic Disease, Cardiovascular Disease), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2027

Hereditary Genetic Testing Market definition and Estimation

Genetic testing additionally called as DNA testing is a sort of medical trial that recognize changes in proteins, qualities or chromosomes. The test outcomes can affirm or preclude an estimated basic genetic condition or help in deciding a person's possibility of creating or passing on a hereditary problem.

 The hereditary Genetic Testing Market is predicted to grow at a CAGR of 10.1 % , from $ 12,682 million in 2019 to $ 21,260 million in 2027.    

Hereditary Genetic Testing Market Overview

 The hereditary Genetic testing market is drawn out and requires the experience of genetic instructors and medical geneticists to help with choosing the most appropriate test for a patient. Also, advances and upgrades in Genetic testing innovation are significantly affecting the market development as these tests precisely analyze various diseases. Moreover, the COVID-19 outbreak impartially affects the Hereditary Genetic testing market, attributable to a decrease in test methodology because of lockdown in practically all parts of the world. The adverse effects of the pandemic on the market took a turn during this pandemic which affected the market on large scale.

The worldwide Hereditary Genetic testing market is relied upon to enlist generous development later on, attributable to ascend in incidents of hereditary disorders and malignancy and ascend in acceptance and acknowledgment of medicines. For example, genetic testing has been broadly utilized in pharmacogenomics, likewise eluded as drug quality testing. Also, progressions in hereditary genetic testing techniques are relied upon to support the genetic testing market development during the forecast period . For example, the Healthcare system in non-industrial countries, for example, Brazil, India, and China have encountered a critical expansion in investments in medical care and infrastructure, which prompts flood popularity for genetic testing around there.

Hereditary Genetic Testing Market Segmentation

By Type

  • Predictive & Presymptomatic Testing
  • Carrier Testing
  • Prenatal & Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

By Technology

  • Cytogenetic Testing
  • Biochemical Testing
  • Molecular Testing 

By Application

  • Cancer diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis

By Type:

By type, the Hereditary Genetic testing market is segmented into prescient testing and presymptomatic testing, Carrier Testing, pre-natal and newborn testing, diagnostics testing, pharmacogenomics testing, and others. The pre-birth and newborn testing fragment stood firm on predominant foothold with most noteworthy revenue, and is required to keep up its strength during the forecast. This is owing to development in awareness among individuals with respect to medical care and expansion in rates of death rate from genetic sicknesses across the world. Then again, the pharmacogenomics testing part is expected to witness most noteworthy CAGR during the forecast period.

By Technology:

The atomic testing section obtained the major hereditary genetic testing share of the overall industry and is relied upon to keep a lead during the forecast time frame. The development of this segment is credited to the way that sub-atomic testing is the most utilized technology for genetic testing. For example, the technology is utilized in hereditary tests, for example, carrier testing, demonstrative testing, prescient and presymptomatic testing, and others. Moreover, molecular testing is preferred, liked as it very well be utilized to analyze gains or misfortunes in DNA that are not distinguishable with routine chromosome analysis.

Hereditary Genetic Testing Market

Hereditary Genetic Testing Market Geography Overview

Region wise, North America was the main revenue supporter of the global hereditary genetic testing market, and was relied upon to rule the market during the forecast period. North America hereditary genetic testing market size was over USD 8.5 billion of every 2020 by virtue of the rising number of malignant growth cases and other ongoing sicknesses just as quickly developing older populace base. 

 In any case, Asia-Pacific is relied upon to develop at the most noteworthy CAGR during the estimated time, inferable from expansion in affordability, flood in medical services use, and ascend unawareness toward early screening of genetic issues.   Moreover, expanding acknowledgment of new technologies, rising patient awareness for early sickness diagnosis and developing frequency of genetic infections will help the general hereditary Genetic testing market expansion.

Hereditary Genetic Testing Market DORC:

Growth Drivers -

  • Rising Prevalence of Genetic Disorders
  • Increasing Prevalence of Various Types of Cancer, Globally
  • Increasing Research Funding in the Field of Genomics

Market Challenges -

  • Expensive Sequencing Procedures and Their Applications in Medical Treatments
  • High Capital Requirement Hampering the Expansion of Global Reach
  • Stringent Regulatory Standards

Market Opportunities -

  • Technological Advancements for Exome Sequencing
  • Rise of Direct-to-Consumer (DTC) Testing Services
  • Massive Scope for Adoption of NGS-Based in Emerging Nations

Key Players:

The worldwide hereditary genetic testing have profoundly aggressive and the noticeable parts in the market have embraced different systems to collect greatest genetic testing share of the overall market. Major key players working in the market incorporate Abbott Laboratories, Bio-Rad Laboratories, Inc. (raindance Technologies, Inc.), Myriad Genetics, Inc. (Bunch RBM, Inc.), Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and CSL Ltd.

Recent News & Developments:

  • Ambry Genetics and Intalere Teams partnered in April 2019. As a result of this partnership, the firm was able to have greater access to healthcare facilities with genetic research in order to better treat patients with elevated cancer risks
  • 23andMe announced the introduction of a novel genetic test in March 2018 that assesses the risk of type 2 diabetes. The company's customer base and market share have grown as a result of this launch.

Frequently Asked Questions (FAQs)

The total market value of genetic testing market is $12,682 million in 2019.

The forecast period for genetic testing market is 2020 to 2027

The base year is 2019 in genetic testing market

Prenatal and newborn testing segment is the most influencing segment as newborn testing is very vital and the awareness related to it is on a rise across the globe. In addition, people are also becoming aware about the importance of prenatal testing which leads to surge in demand for prenatal testing across the globe.

Top companies such as, Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Qiagen N.V., and Myriad Genetics, Inc. held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

Chapter 1.  Research Objective

  1. Objective, Definition & Scope
  2. Methodology
    1. Primary Research
    2. Secondary Research
    3. Market Forecast - Estimation & Approach
    4. Assumptions & Assessments
  3. Insights and Growth - Relevancy Mapping
    1. FABRIC Platform
  4. Data mining & efficiency

Chapter 2.  Executive Summary

  1. Hereditary genetic Packaging Market Overview
  2. Interconnectivity & Related markets
  3. Ecosystem Map
  4. Hereditary genetic Market Business Segmentation
  5. Hereditary genetic Market Geographic Segmentation
  6. Competition Outlook
  7. Key Statistics

Chapter 3.  Strategic Analysis

  1. Hereditary genetic Market Revenue Opportunities
  2. Cost Optimization
  3. Covid19 aftermath - Analyst view
  4. Hereditary genetic Market Digital Transformation

Chapter 4.  Market Dynamics

  1. DROC
    1. Drivers
      1. Rising Prevalence of Genetic Disorders
      2. Increasing Prevalence of Various Types of Cancer, Globally
      3. Increasing Research Funding in the Field of Genomics
  2. Restraints
    1. Expensive Sequencing Procedures and Their Applications in Medical Treatments
    2. High Capital Requirement Hampering the Expansion of Global Reach

     4.1.3 Opportunities

    • Technological Advancements for Exome Sequencing
    • Rise of Direct-to-Consumer (DTC) Testing Services
  1. PEST Analysis
    1. Political
    2. Economic
    3. Social
    4. Technological
  2. Market Impacting Trends
    1. Positive Impact Trends
    2. Adverse Impact Trends
  3. Porter's 5-force Analysis
  4. Market News - By Segments
    1. Organic News
    2. Inorganic News
  5. Price Trend Analysis

Chapter 5. Market Segmentation

  1. Global Hereditary genetic Market Segmentation by Type- Forecast till 2027
    1. Presymptomatic  Testing
    2. Carrier testing
    3. Prenatal & New-born testing
    4. Diagnostics testing
  2. Global Hereditary genetic Market Segmentation by Application- Forecast till 2027
    1. Cancer Diagnosis
    2. Genetic disease diagnosis
    3. Cardiovascular diagnosis
    4. Others


North America Hereditary genetic Market Segmentation

By Technology - Forecast till 2027

By Product - Forecast till 2027

By End-user - Forecast till 2027


Europe Hereditary genetic Market Segmentation

By Technology - Forecast till 2027

By Product - Forecast till 2027

By End-user - Forecast till 2027


APAC Hereditary genetic Market Segmentation

By Technology - Forecast till 2027

By Product - Forecast till 2027

By End-user - Forecast till 2027


Latin America (LATAM   Hereditary genetic Market Segmentation

By Technology - Forecast till 2027

By Product - Forecast till 2027

By End-user - Forecast till 2027


The regions are further studied to analyze the major countries within the respective regions. The coverage of the country level data is dynamic and is updated regularly based on the market movements. Normally, the countries covered in the report include

North America - United States, Canada, Mexico; Europe - United Kingdom, France, Italy, Germany, Spain, Rest of Europe; Asia Pacific - China, India, Japan, South Korea, Rest of APAC; Middle East & Africa - South Africa, GCC Countries, Rest of MEA; LatAm - Brazil, Argentina, Rest of LatAm;

Chapter 6.  Market Use case studies

Chapter 7.  KOL Recommendations

Chapter 8.  Investment Landscape

8.1 Hereditary genetic Market Investment Analysis

8.2 Market M&A

8.3 Market Fund Raise & Other activity

Chapter 9. Global Hereditary genetic Market - Competitive Intelligence

9.1 Company Positioning Analysis

   9.1.1 Positioning - By Revenue

   9.1.2 Positioning - By Business Score

   9.1.3 Legacy Positioning

9.2 Competitive Strategy Analysis

   9.2.1 Organic Strategies

   9.2.2 Inorganic Strategies

Chapter 10.  Key Company Profiles

The Hereditary genetic market report profiles companies based on the material impact they have on the market ecosystem. These are hence, to be read as 'Key Players' and not necessarily 'Market Leaders'.

Companies are typically profiled to include

10.x.1 Company Fundamentals

10.x.2 Performance Overview

10.x.3 Product Overview

10.x.4 Recent Developments


The Companies profiled in this Report include

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc. (Raindance Technologies, Inc.)
  • Csl Ltd.
  • Danaher Corporation (Cepheid)
  • Eurofins Scientific
  •  Hoffmann-La Roche Ltd.
  • .Myriad Genetics, Inc
  • Qiagen N.V. (Formulatrix, Inc.)

Chapter 11.  Appendix

11.1 About AllTheResearch

11.2 Service offerings

11.3 Author details

11.4 Terms & Conditions

11.5 Contact us

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization